Novo Nordisk A/S (NVO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Novo Nordisk A/S, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 14.05x | 27.33x | 36.93x | 38.35x | 35.21x | 23.56x |
| P/B Ratio | 7.42x | 19.23x | 29.00x | 25.50x | 23.77x | 95.38x |
| P/S Ratio | 4.66x | 9.50x | 13.31x | 12.03x | 11.94x | 7.82x |
| Profitability | ||||||
| Gross Margin | 81.0% | 84.7% | 84.6% | 83.9% | 83.2% | 83.5% |
| Operating Margin | 41.3% | 44.2% | 44.2% | 42.3% | 41.7% | 42.6% |
| Net Margin | 33.1% | 34.8% | 36.0% | 31.4% | 33.9% | 33.2% |
| EBITDA Margin | 50.7% | 50.9% | 49.4% | 43.4% | 46.4% | 46.7% |
| Liquidity | ||||||
| Current Ratio | 0.80x | 0.74x | 0.82x | 0.89x | 0.86x | 0.94x |
| Quick Ratio | 0.57x | 0.55x | 0.64x | 0.69x | 0.66x | 0.67x |
| Leverage | ||||||
| Debt/Equity | 0.67x | 0.72x | 0.25x | 0.31x | 0.38x | 0.16x |
YoY = year-over-year change. Source: FMP..